Current Edition

clinical

NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment

What Preliminary findings from a large clinical trial, the Systolic Blood Pressure Intervention Trial (SPRINT) Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study will …

Continue Reading →
clinical

Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer

Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1 against heavily pretreated HER2-positive breast …

Continue Reading →
announces

Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson’s Disease Published in JAMA Neurology

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience category, today announced that results …

Continue Reading →
cancer

Doctors Call Off Clinical Trial After Experimental Cancer Treatment Has Tragic Results

 A recent clinical trial attempting to rid three patients of an uncommon type of blood cancer has gone tragically wrong. Rather than fighting the cancer that …

Continue Reading →
Arzerra

Genmab Announces Topline Results in Phase III study of Arzerra® in Indolent Non-Hodgkin’s Lymphoma

Topline results from Phase III study in iNHL did not meet primary endpoint of improved progression-free survival Genmab A/S (Nasdaq Copenhagen: GEN) announced today that …

Continue Reading →
3

Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis

U.S. regulatory submission for patients ages 12-17 planned for third quarter 2018 A pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat moderate-to-severe atopic dermatitis …

Continue Reading →
boosts

Virtual drug trials boost results

Bringing drug trials to the virtual realm, Belinda Tan ’96 has found a way to cut entire process in half. Bringing a new drug to …

Continue Reading →